United States Immunotherapy Drugs Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Alligator Bioscience, Bristol-Myers Squibb, Novartis AG and AstraZeneca

Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Immunotherapy Drugs Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/immunotherapy-drugs-market?sg

Key Players: Daiichi Sankyo Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, AbbVie, Inc., Amgen, Inc., Merck & Co., Inc., Alligator Bioscience, Bristol-Myers Squibb, Novartis AG and AstraZeneca.

United States - Industry Latest News:

✅ FDA approved Merck's Keytruda Qlex on September 19, 2025, a subcutaneous formulation offering faster administration for various solid tumors.

✅ Genentech's Tecentriq plus lurbinectedin received FDA approval on October 2, 2025, as first-line maintenance therapy for extensive-stage small cell lung cancer.

✅ Sun Pharmaceutical Industries announced the acquisition of Checkpoint Therapeutics for $355 million on March 10, 2025, enhancing its oncology and immunotherapy portfolio.

Europe - Industry Latest News:

✅ Ipsen agreed to acquire ImCheck Therapeutics for €1 billion on October 22, 2025, focusing on first-line acute myeloid leukemia treatment.

✅ BioNTech launched an exchange offer on October 22, 2025, moving forward with a $1.25 billion acquisition of CureVac to expand its immunotherapy capabilities.

Asia - Industry Latest News:

✅ Innovent Biologics announced a global strategic partnership with Takeda on October 21, 2025, to bring next-generation immuno-oncology therapies and antibody-drug conjugates to the global market.

Mergers & Acquisitions

✅ October 21, 2025: Innovent Biologics announced a global strategic partnership with Takeda to advance next-generation immuno-oncology therapies and antibody-drug conjugates.

✅ June 2, 2025: Sanofi agreed to acquire Blueprint Medicines, expanding its portfolio in rare immunological diseases and adding an early-stage pipeline in immunology.

Research Breakthroughs

✅ October 17, 2025: MD Anderson Cancer Center presented promising results at ESMO 2025, showing that an oral drug demonstrates anti-tumor activity in patients with advanced lung cancer.

✅ October 22, 2025: Reuters reported that mRNA COVID-19 vaccines appear to enhance the effectiveness of immunotherapy cancer drugs.

Growth Forecast Projected:

The Global Immunotherapy Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Immunotherapy Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=immunotherapy-drugs-market?sg

Key Segments:

By Drug Type - Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins Checkpoint Inhibitors, Others

By Therapy Area - Oncology, Autoimmune and Inflammatory Diseases, Infectious Diseases, Others

By End User - Hospitals, Clinics, Cancer Research Centers, Others

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Immunotherapy Drugs producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Immunotherapy Drugs revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/immunotherapy-drugs-market?sg

FAQ's

Q1: What is the current size of the Immunotherapy Drugs Market?

A: The Immunotherapy Drugs Market stood at US$ 288.02 Billion in 2024 and is set to experience remarkable growth, reaching US$ 872.64 Billion by 2033

Q2: How fast is the Immunotherapy Drugs Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 13.2% from 2025-2033

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/immunotherapy-drugs-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.